Dimed Distribuidora de Medicamentos (BSP:PNVL3) Net Income From Continuing Operations : R$97 Mil (TTM As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Dimed Distribuidora de Medicamentos's net income from continuing operations for the three months ended in Mar. 2025 was R$25 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was R$97 Mil.

Dimed Distribuidora de Medicamentos Net Income From Continuing Operations Historical Data

The historical data trend for Dimed Distribuidora de Medicamentos's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimed Distribuidora de Medicamentos Net Income From Continuing Operations Chart

Dimed Distribuidora de Medicamentos Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

56.15

79.43

86.35

92.91

105.51

Dimed Distribuidora de Medicamentos Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															33.55	5.13	35.86	30.97	25.47

Dimed Distribuidora de Medicamentos Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$97 Mil.

Dimed Distribuidora de Medicamentos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000

Website

https://www.grupopanvel.com.br

Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos Headlines

No Headlines